1062159-35-6,MFCD22419019
Catalog No.:AA008YUM

1062159-35-6 | Way-600

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$128.00   $89.00
- +
5mg
in stock  
$411.00   $288.00
- +
10mg
in stock  
$543.00   $380.00
- +
50mg
in stock  
$1,331.00   $932.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008YUM
Chemical Name:
Way-600
CAS Number:
1062159-35-6
Molecular Formula:
C28H30N8O
Molecular Weight:
494.5908
MDL Number:
MFCD22419019
SMILES:
O1CCN(CC1)c1nc(nc2c1cnn2C1CCN(CC1)Cc1cccnc1)c1ccc2c(c1)cc[nH]2
Properties
Computed Properties
 
Complexity:
744  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
37  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3  

Downstream Synthesis Route
1062159-35-6    164365-88-2   
C37H47N9O3 

[1]Patent:WO2018/204416,2018,A1.Locationinpatent:Paragraph00334

[2]Patent:WO2019/212991,2019,A1.Locationinpatent:Paragraph00438

1062159-35-6    164365-88-2    76-05-1   
4-(5-(4-morpholino-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo3,4-dpyrimidin-6-yl)-1H-indol-1-yl)butan-1-aminetrifluoroaceticacidsalt 

[1]Patent:WO2019/212991,2019,A1.Locationinpatent:Paragraph00438

Literature

Title: Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase.

Journal: Journal of medicinal chemistry 20091126

Title: Yu K, et al. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 2009 Aug 1;69(15):6232-40.

Title: Wang K, et al. MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models. Biochem Biophys Res Commun. 2016 May 27;474(2):330-7.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1062159-35-6
Historical Records
Tags:1062159-35-6 Molecular Formula|1062159-35-6 MDL|1062159-35-6 SMILES|1062159-35-6 Way-600
Catalog No.: AA008YUM
1062159-35-6,MFCD22419019
1062159-35-6 | Way-600
Pack Size: 1mg
Purity: ≥98%
in stock
$128.00 $89.00
Pack Size: 5mg
Purity:
in stock
$411.00 $288.00
Pack Size: 10mg
Purity:
in stock
$543.00 $380.00
Pack Size: 50mg
Purity:
in stock
$1,331.00 $932.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008YUM
Chemical Name: Way-600
CAS Number: 1062159-35-6
Molecular Formula: C28H30N8O
Molecular Weight: 494.5908
MDL Number: MFCD22419019
SMILES: O1CCN(CC1)c1nc(nc2c1cnn2C1CCN(CC1)Cc1cccnc1)c1ccc2c(c1)cc[nH]2
Properties
Complexity: 744  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 37  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3  
Downstream Synthesis Route
1062159-35-6    164365-88-2   
C37H47N9O3 

[1]Patent:WO2018/204416,2018,A1.Locationinpatent:Paragraph00334

[2]Patent:WO2019/212991,2019,A1.Locationinpatent:Paragraph00438

1062159-35-6    164365-88-2    76-05-1   
4-(5-(4-morpholino-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo3,4-dpyrimidin-6-yl)-1H-indol-1-yl)butan-1-aminetrifluoroaceticacidsalt 

[1]Patent:WO2019/212991,2019,A1.Locationinpatent:Paragraph00438

Literature fold

Title: Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase.

Journal: Journal of medicinal chemistry20091126

Title: Yu K, et al. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 2009 Aug 1;69(15):6232-40.

Title: Wang K, et al. MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models. Biochem Biophys Res Commun. 2016 May 27;474(2):330-7.

Building Blocks More >
1187932-68-8
1187932-68-8
(3-(Trifluoromethyl)pyridin-2-yl)methanamine hydrochloride
AA008Z28 | MFCD04117764
1093402-61-9
1093402-61-9
Benzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanone hydrochloride
AA008ZOQ | MFCD10534024
1072945-77-7
1072945-77-7
2-Chloro-6-fluoro-3-methoxyphenylboronic acid
AA0090CD | MFCD09972096
1185296-74-5
1185296-74-5
3-(Tetrahydrofuran-3-yl)propan-1-amine hydrochloride
AA0090JP | MFCD09800618
1201633-56-8
1201633-56-8
1-Acetyl-1,4-diazepane hydrochloride
AA0090V2 | MFCD13248809
1005584-44-0
1005584-44-0
2-(4-Bromo-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)propanoic acid
AA0090XS | MFCD03419689
1185168-06-2
1185168-06-2
N-DESMETHYL SILDENAFIL-D8
AA0091TN | MFCD11977920
1120214-86-9
1120214-86-9
tert-Butyl 4-(3,8-diazabicyclo[3.2.1]octan-8-yl)piperidine-1-carboxylate
AA009231 | MFCD14279202
1094702-34-7
1094702-34-7
5-(Trifluoromethyl)isoxazole-4-carboxylic acid
AA0092HN | MFCD11620299
1204811-26-6
1204811-26-6
3-(4-Nitrobenzylamino)pyrrolidine-1-carboxylic acid tert-butyl ester
AA0092ZM | MFCD12963738
Submit
© 2017 AA BLOCKS, INC. All rights reserved.